Published by Josh White on 22nd March 2023
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals said on Wednesday that it had received positive feedback from the US Food and Drug Administration (FDA) on the development of its precision immunotherapy asset 'bexmarilimab'.
URL: http://www.digitallook.com/dl/news/story/33386638/...